Developmental Research Program
Developmental Research Program
批准号:
10268747
负责人:
Meenhard F Herlyn
金额:
$8.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-03 至 2026-07-31
关键词:
Applications GrantsCancer CenterCancer PatientCutaneous MelanomaDevelopmentEnsureExtramural ActivitiesFacultyFosteringFundingFutureGoalsGrantMeasuresMonitorPaperPatient CarePeer ReviewPilot ProjectsProceduresProcessProgram DevelopmentProgress ReportsPublicationsResearchResearch PersonnelResearch Project GrantsResourcesReview CommitteeSkin CancerSkin CarcinomaThe Wistar InstituteUnderrepresented MinorityWomananticancer researchcancer research center directorexpectationhigh standardinterestminority scientistprogramsrecruitresearch and developmentresearch studysuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary – Developmental Research Program
In the previous cycle, the Wistar/UPenn SPORE Development Research Program (DRP) was led by Dr. Robert
Vonderheide, who has since become the Cancer Center Director of the Abramson Cancer Center. The DRP
recruited a diverse array of investigators from many fields into melanoma and skin cancer research. The result
has been an outstanding number of high impact papers, extramural grants, and two projects graduating from the
DRP into full projects in this application. Building on this success, Dr. Meenhard Herlyn and Dr. Ravi Amaravadi,
the co-Directors of this SPORE grant will serve as DRP co-Directors in the new cycle. The overall goals of the
DRP in the new grant period remain to advance high quality research, foster new ideas, and move research
studies from pilot to project status. A second goal of the DRP is to create opportunities for the scientific
development of junior faculty or senior investigators who are interested in transitioning into skin cancer research.
Our approach is summarized in 2 specific aims and is enabled by a strong commitment for an exceptional level
of institutional support from The Wistar Institute and UPenn. The DRP will, in particular, welcome projects on
non-melanoma skin cancers and topics not covered by the funded full Projects. Aim 1 is to attract, select and
fund the most outstanding proposals with significant potential to benefit the Skin Cancer SPORE and
translational skin cancer research. Specific research projects are summarized that represent all cancers of the
skin. Aim 2 is to support and integrate the selected pilot projects into the SPORE program with established
processes to review and monitor progress. Women and underrepresented minorities will be strongly encouraged
to participate. The DRP has a transparent peer-reviewed selection process that incorporates defined criteria for
funding decisions. We require that DRP awardees be active in SPORE functions, use the SPORE Core resource,
and provide formal written progress reports. Within the context of the DRP, we have established high standards
and expectations of the investigators and have established a formal process to review and monitor progress of
funded pilot projects. The Program measures success by publications, extramural funding, stimulating new aims
in existing SPORE Projects, and elevation to full projects for the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gamma delta T cell based melanoma therapies
-
批准号:10365762
-
项目类别:
-
资助金额:$66.67万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10381269
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10268741
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Neoadjuvant immunotherapy approaches to early stage melanoma
-
批准号:10480856
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Developmental Research Program
-
批准号:10480863
-
项目类别:
-
资助金额:$8.84万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10480830
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Gamma delta T cell based melanoma therapies
-
批准号:10540374
-
项目类别:
-
资助金额:$63.27万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Explore Gamma delta T cell-based glioblastoma therapies
-
批准号:10829731
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Neoadjuvant immunotherapy approaches to early stage melanoma
-
批准号:10268746
-
项目类别:
-
资助金额:$46.67万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10307107
-
项目类别:
-
资助金额:$49.38万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:9887923
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10737745
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10524132
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10532797
-
项目类别:
-
资助金额:$49.38万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
PDX Core
-
批准号:10681841
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Research Project 1 - Targeting the MAPK and PI3K pathways in melanoma PDX
-
批准号:10681844
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10681840
-
项目类别:
-
资助金额:$7.04万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
PDX Core
-
批准号:10733194
-
项目类别:
-
资助金额:$11.21万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Pilot-Trans Network Core
-
批准号:10733198
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10494403
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
海外基金